SCHEMBL3230218

SCHEMBL3230218

CCOc1ccc2c(c1)C(C)(c1ccccc1Cl)C(=O)N2S(=O)(=O)c1ccc(C(=O)NC(C)(C)CO)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GNRHR P30968 3/20 0.39
MAPT P10636 3/20 0.38
RECQL P46063 1/20 0.38
AVPR1A P37288 1/20 0.38
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
HTT P42858 2/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
EPHX2 P34913 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
USP2 O75604 1/20 0.35
POLB P06746 1/20 0.35
CYP2C9 P11712 1/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3230306 0.95 HTT (0.43) ALDH1A1HPGDKDM4EGNRHRMAPT
SCHEMBL3235527 0.93 GNRHR (0.39) ALDH1A1HPGDKDM4EGNRHRMAPT
SCHEMBL3226270 0.93 GNRHR (0.39) ALDH1A1HPGDKDM4EGNRHRMAPT
SCHEMBL3233628 0.93 AVPR1A (0.43) ALDH1A1HPGDKDM4EGNRHRMAPT
SCHEMBL3231008 0.92 GNRHR (0.39) ALDH1A1HPGDKDM4EGNRHRMAPT
SCHEMBL3226477 0.86 KMT2A (0.40) ALDH1A1HPGDKDM4EGNRHRMAPT
SCHEMBL3234028 0.85 GNRHR (0.39) ALDH1A1GNRHRMAPTRECQLAVPR1A
SCHEMBL3236849 0.84 AVPR1A (0.45) ALDH1A1MAPTRECQLAVPR1AMEN1
SCHEMBL3225064 0.84 HPGD (0.44) ALDH1A1HPGDKDM4EGNRHRMAPT
SCHEMBL3228428 0.84 AVPR1A (0.43) ALDH1A1HPGDGNRHRMAPTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097374-B1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY AS SELECTIVE LIGANDS OF V2 VASOPRESSIN RECEPTORS SANOFI AVENTIS (FR) 2010-06-09 EP claimed
US-20100069384-A1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY SANOFI-AVENTIS (FR) 2010-03-18 US claimed
US-20100069384-A1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY SANOFI-AVENTIS (FR) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069384-A1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY AVPR2, AVPR1A, AVPR1B ALDH1A1 3212/4885HPGD 271/4885KDM4E 4170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.